The landscape of dementia diagnosis has evolved significantly with the advent of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly checks that could detect Alzheimer's pathology a long time before signs or symptoms emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've https://neuropsychologicaltesting66543.suomiblog.com/the-enduring-price-of-cognitive-evaluation-for-older-older-people-53819008